News - Pharmaceuticals
Policymakers ‘dragging the anchor’ leaves Alzheimer’s patients stranded at the edge of hope
Alzheimer’s disease has long been framed as an unsolvable puzzle – slow, relentless, and devastating for patients and families alike. […]
MoreNews - MedTech & Diagnostics
A national first: Private hospital funding linked to patient-reported outcomes
The nation’s largest health insurance buying group has broken new ground in healthcare funding by linking private hospital payments directly […]
MoreNews - Biotechnology
Secrecy and monopoly concerns shadow Moderna’s mRNA facility
Australia’s first large-scale mRNA manufacturing facility promises significant economic and health dividends, but critics warn it gives one global company […]
MoreDigital & Innovation
Virtual cardiac rehab cuts hospital readmission days by 70%
A virtual cardiac rehabilitation program is showing significant promise in reshaping chronic disease management, with a new evaluation revealing it […]
MoreLeadership & Management
Ipsen ushers in new leadership to steer ANZ operations
Ipsen has appointed Dagmar Tschoep as General Manager for Australia & New Zealand, effective 1 October 2025. She succeeds Julien […]
MoreESG
First climate risk report delivers dire warning: Will policy catch up?
The federal government’s release of the inaugural National Climate Risk Assessment highlights the serious impacts of climate change on human […]
MoreHuman Resources
Merck, Edwards Lifesciences, Daiichi Sankyo and Telix crowned Excellence Awardees: Australian HR Awards
Merck, Edwards Lifesciences, Daiichi Sankyo, and Telix Pharmaceuticals have emerged as Excellence Awardees at the Australian HR Awards, highlighting their […]
MoreMedical and Science
Landmark analysis maps a skewed cancer trials landscape
A review of more than 89,000 cancer clinical trials conducted over two decades has produced what researchers are calling the […]
MoreCommunication
Mastering the art of saying ‘No’ to protect your career and well-being: Psychologist
As the year draws to a close, professionals and leaders alike are faced with increasing pressure to meet deadlines, complete […]
MoreMarketing & Strategy
Bayer, MSD and Takeda among winners at Asia Pacific awards
Bayer, MSD, Takeda, Alcon, and Cipla emerge as winners among this week’s announcements of Asia Pacific awards which celebrate organisations […]
MoreLatest News in Pharma, MedTech, Diagnostics & Biotech
Policymakers ‘dragging the anchor’ leaves Alzheimer’s patients stranded at the edge of hope
September 26, 2025
in News - Pharmaceuticals
IBD experts forge their own path as policymakers fail to deliver
September 26, 2025
in News - Pharmaceuticals
A national first: Private hospital funding linked to patient-reported outcomes
September 26, 2025
in News - MedTech & Diagnostics
Rearranging the deckchairs won’t cut it: Lived experience must drive health policy decisions
September 26, 2025
in News - Pharmaceuticals
Stryker’s Mako 4 robotic system gains traction in private hospitals
September 26, 2025
in News - MedTech & Diagnostics
Eisai and Biogen secure TGA nod for Alzheimer’s drug, but questions linger
September 25, 2025
in News - Pharmaceuticals
Pathology Technology Australia appoints new Board members to drive next phase of strategic plan
September 25, 2025
in News - MedTech & Diagnostics
Bupa rolls out pharmacogenomic testing as government moves on long-stalled ban on genetic discrimination
September 25, 2025
in News - MedTech & Diagnostics
Decoding Alzheimer’s at the crossroads of science and policy
September 24, 2025
in News - MedTech & Diagnostics
Secrecy and monopoly concerns shadow Moderna’s mRNA facility
September 24, 2025
in News - Biotechnology
Clinicians map role of MSD drug in pulmonary arterial hypertension post PBAC rejection
September 24, 2025
in News - Pharmaceuticals
Healthcare system failing young Aussies: Three in four forced to change care due to cost
September 24, 2025
in News - MedTech & Diagnostics
Patients say ‘no more reviews or rhetoric’ as HTA reform crawls
September 22, 2025
in News - Pharmaceuticals
Four pharma leaders vie for two Medicines Australia Board seats
September 22, 2025
in News - Pharmaceuticals
Charting a shared path: Patients, clinicians and industry unite for aggressive lymphoma
September 22, 2025
in News - Pharmaceuticals
Colonoscopy access: Postcode and pay packet still dictate outcomes
September 22, 2025
in News - MedTech & Diagnostics
Productivity Commission interim reports spur health sector calls for crucial mindset shift
September 19, 2025
in News - Pharmaceuticals
MTAA Board election kicks off, setting stage for industry’s next chapter in policy and advocacy
September 19, 2025
in News - MedTech & Diagnostics
Sanofi tackles healthcare’s trust gap with one in a million conversations
September 19, 2025
in News - Pharmaceuticals
Follow Us
Partner with us
News - Pharmaceuticals
Policymakers ‘dragging the anchor’ leaves Alzheimer’s patients stranded at the edge of hope
Alzheimer’s disease has long been framed as an unsolvable puzzle – slow, relentless, and devastating for patients and families alike. […]
MoreNews - Pharmaceuticals
IBD experts forge their own path as policymakers fail to deliver
Australia faces significant gaps in delivering consistent, high-quality care for the 180,000 people living with Inflammatory Bowel Disease (IBD). While […]
MoreNews - MedTech & Diagnostics
A national first: Private hospital funding linked to patient-reported outcomes
The nation’s largest health insurance buying group has broken new ground in healthcare funding by linking private hospital payments directly […]
MoreNews - Pharmaceuticals
Rearranging the deckchairs won’t cut it: Lived experience must drive health policy decisions
Boehringer Ingelheim has unveiled a white paper at a high-level roundtable during the United Nations General Assembly (UNGA) in New […]
More